Use of beta blockers in patients with reactive airway disease and concomitant hypertension or ischemic heart disease

Rahul Magazine, Bharti Chogtu, Dhanya Soodana Mohan, Shruti Nair, Tanwi Trushna

Research output: Contribution to journalArticle

Abstract

Beta-adrenoreceptor antagonists can be safely prescribed and decreases mortality in patients with ischemic heart disease and cardiovascular risk factors. Some authors are of the opinion that there is underuse of beta blockers in this subgroup of patients. The objective of this study was to analyse drugs being prescribed and the effect beta blockers have on symptoms in asthmatics with concomitant reactive airway diseases and cardiovascular diseases. Data was collected from medical records of patients with reactive airway disease and concomitant hypertension and ischemic heart disease. It included demographic details of the patients, the clinical diagnosis, drugs prescribed and the patient outcome regarding whether there was exacerbation of asthma symptoms on taking beta blockers. Medical records of 250 patients were analysed.13% of all patients was prescribed beta blockers. Among hypertensive's 12%, among patients with ischemic heart disease 16.6% and of patients with IHD and hypertension, 20% were prescribed beta blockers. Of the 33 (13%) patients who were on beta blockers, only 3 patients had exacerbation of bronchial asthma symptoms. Prescribing cardioselective beta blockers under supervision appear to be safe in patients with reactive airway disease and concomitant hypertension and ischemic heart disease.

Original languageEnglish
Pages (from-to)1065-1073
Number of pages9
JournalResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Volume5
Issue number1
Publication statusPublished - 01-01-2014

Fingerprint

Myocardial Ischemia
Hypertension
Medical Records
Asthma
Pharmaceutical Preparations
Cardiovascular Diseases
Demography
Mortality

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{a1620c480fe9423bbea2a09ebe098b68,
title = "Use of beta blockers in patients with reactive airway disease and concomitant hypertension or ischemic heart disease",
abstract = "Beta-adrenoreceptor antagonists can be safely prescribed and decreases mortality in patients with ischemic heart disease and cardiovascular risk factors. Some authors are of the opinion that there is underuse of beta blockers in this subgroup of patients. The objective of this study was to analyse drugs being prescribed and the effect beta blockers have on symptoms in asthmatics with concomitant reactive airway diseases and cardiovascular diseases. Data was collected from medical records of patients with reactive airway disease and concomitant hypertension and ischemic heart disease. It included demographic details of the patients, the clinical diagnosis, drugs prescribed and the patient outcome regarding whether there was exacerbation of asthma symptoms on taking beta blockers. Medical records of 250 patients were analysed.13{\%} of all patients was prescribed beta blockers. Among hypertensive's 12{\%}, among patients with ischemic heart disease 16.6{\%} and of patients with IHD and hypertension, 20{\%} were prescribed beta blockers. Of the 33 (13{\%}) patients who were on beta blockers, only 3 patients had exacerbation of bronchial asthma symptoms. Prescribing cardioselective beta blockers under supervision appear to be safe in patients with reactive airway disease and concomitant hypertension and ischemic heart disease.",
author = "Rahul Magazine and Bharti Chogtu and Mohan, {Dhanya Soodana} and Shruti Nair and Tanwi Trushna",
year = "2014",
month = "1",
day = "1",
language = "English",
volume = "5",
pages = "1065--1073",
journal = "Research Journal of Pharmaceutical, Biological and Chemical Sciences",
issn = "0975-8585",
publisher = "RJPBCS",
number = "1",

}

Use of beta blockers in patients with reactive airway disease and concomitant hypertension or ischemic heart disease. / Magazine, Rahul; Chogtu, Bharti; Mohan, Dhanya Soodana; Nair, Shruti; Trushna, Tanwi.

In: Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 5, No. 1, 01.01.2014, p. 1065-1073.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Use of beta blockers in patients with reactive airway disease and concomitant hypertension or ischemic heart disease

AU - Magazine, Rahul

AU - Chogtu, Bharti

AU - Mohan, Dhanya Soodana

AU - Nair, Shruti

AU - Trushna, Tanwi

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Beta-adrenoreceptor antagonists can be safely prescribed and decreases mortality in patients with ischemic heart disease and cardiovascular risk factors. Some authors are of the opinion that there is underuse of beta blockers in this subgroup of patients. The objective of this study was to analyse drugs being prescribed and the effect beta blockers have on symptoms in asthmatics with concomitant reactive airway diseases and cardiovascular diseases. Data was collected from medical records of patients with reactive airway disease and concomitant hypertension and ischemic heart disease. It included demographic details of the patients, the clinical diagnosis, drugs prescribed and the patient outcome regarding whether there was exacerbation of asthma symptoms on taking beta blockers. Medical records of 250 patients were analysed.13% of all patients was prescribed beta blockers. Among hypertensive's 12%, among patients with ischemic heart disease 16.6% and of patients with IHD and hypertension, 20% were prescribed beta blockers. Of the 33 (13%) patients who were on beta blockers, only 3 patients had exacerbation of bronchial asthma symptoms. Prescribing cardioselective beta blockers under supervision appear to be safe in patients with reactive airway disease and concomitant hypertension and ischemic heart disease.

AB - Beta-adrenoreceptor antagonists can be safely prescribed and decreases mortality in patients with ischemic heart disease and cardiovascular risk factors. Some authors are of the opinion that there is underuse of beta blockers in this subgroup of patients. The objective of this study was to analyse drugs being prescribed and the effect beta blockers have on symptoms in asthmatics with concomitant reactive airway diseases and cardiovascular diseases. Data was collected from medical records of patients with reactive airway disease and concomitant hypertension and ischemic heart disease. It included demographic details of the patients, the clinical diagnosis, drugs prescribed and the patient outcome regarding whether there was exacerbation of asthma symptoms on taking beta blockers. Medical records of 250 patients were analysed.13% of all patients was prescribed beta blockers. Among hypertensive's 12%, among patients with ischemic heart disease 16.6% and of patients with IHD and hypertension, 20% were prescribed beta blockers. Of the 33 (13%) patients who were on beta blockers, only 3 patients had exacerbation of bronchial asthma symptoms. Prescribing cardioselective beta blockers under supervision appear to be safe in patients with reactive airway disease and concomitant hypertension and ischemic heart disease.

UR - http://www.scopus.com/inward/record.url?scp=84894092470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894092470&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84894092470

VL - 5

SP - 1065

EP - 1073

JO - Research Journal of Pharmaceutical, Biological and Chemical Sciences

JF - Research Journal of Pharmaceutical, Biological and Chemical Sciences

SN - 0975-8585

IS - 1

ER -